Vitamin D3 -: implications for brain development

被引:100
作者
McGrath, JJ [1 ]
Féron, FP
Burne, THJ
Mackay-Sim, A
Eyles, DW
机构
[1] Pk Ctr Mental Hlth, Queensland Ctr Schizophrenia Res, Wacol, Qld 4076, Australia
[2] Univ Queensland, Dept Psychiat, St Lucia, Qld 4072, Australia
[3] Griffith Univ, Sch Biomol & Biomed Sci, Ctr Mol Neurobiol, Brisbane, Qld 4111, Australia
[4] Univ Queensland, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia
关键词
1,25-dihydroxyvitamin D-3; vitamin D receptor; brain growth and development; prenatal exposures; nerve growth factor;
D O I
10.1016/j.jsbmb.2004.03.070
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is growing evidence that 1,25-dihydroxyvitamin D-3 (I,25(OH)(2)D-3) is active in the brain but until recently there was a lack of evidence about its role during brain development. Guided by certain features of the epidemiology of schizophrenia, our group has explored the role of 1,25(OH)(2)D-3 in brain development using whole animal models and in vitro culture studies. The expression of the vitamin D receptor (VDR) in the embryonic rat brain rises steadily between embryonic day 15-23, and 1,25(OH)(2)D-3 induces the expression of nerve growth factor and stimulates neurite outgrowth in embryonic hippocampal explant cultures. In the neonatal rat, low prenatal vitamin D-3 in utero leads to increased brain size, altered brain shape, enlarged ventricles, reduced expression of nerve growth factors, reduced expression of the low affinity p75 receptor and increased cellular proliferation. In summary, there is growing evidence that low prenatal levels of 1,25(OH)(2)D-3 can influence critical components of orderly brain development. It remains to be seen if these processes are of clinical relevance in humans, but in light of the high rates of hypovitaminosis D in pregnant women and neonates, this area warrants further scrutiny. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:557 / 560
页数:4
相关论文
共 34 条
  • [1] [Anonymous], 1994, Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), V4th
  • [2] STRUCTURE-FUNCTION-RELATIONSHIPS IN THE VITAMIN-D ENDOCRINE SYSTEM
    BOUILLON, R
    OKAMURA, WH
    NORMAN, AW
    [J]. ENDOCRINE REVIEWS, 1995, 16 (02) : 200 - 257
  • [3] 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons
    Brown, J
    Bianco, JI
    McGrath, JJ
    Eyles, DW
    [J]. NEUROSCIENCE LETTERS, 2003, 343 (02) : 139 - 143
  • [4] Burkert R, 2003, NEUROSCI RES COMMUN, V33, P67
  • [5] A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia
    Davies, G
    Welham, J
    Chant, D
    Torrey, EF
    McGrath, J
    [J]. SCHIZOPHRENIA BULLETIN, 2003, 29 (03) : 587 - 593
  • [6] DELUCA HF, 1990, KIDNEY INT, V38, pS2
  • [7] Vitamin D3 and brain development
    Eyles, D
    Brown, J
    Mackay-Sim, A
    McGrath, J
    Feron, F
    [J]. NEUROSCIENCE, 2003, 118 (03) : 641 - 653
  • [8] New clues about vitamin D functions in the nervous system
    Garcion, E
    Wion-Barbot, N
    Montero-Menei, CN
    Berger, F
    Wion, D
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (03) : 100 - 105
  • [9] Nongenomic signaling by vitamin D - A new face of Src
    Gniadecki, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1998, 56 (10) : 1273 - 1277
  • [10] SEARCHING FOR THE CAUSES OF SCHIZOPHRENIA - THE ROLE OF MIGRANT STUDIES
    HARRISON, G
    [J]. SCHIZOPHRENIA BULLETIN, 1990, 16 (04) : 663 - 671